Cargando...
Rapamycin and Alzheimer’s disease: Time for a clinical trial?
The drug rapamycin has beneficial effects in a number of animal models of neurodegeneration and aging including mouse models of Alzheimer’s disease. Despite its compelling preclinical record, no clinical trials have tested rapamycin or other mTOR inhibitors in patients with Alzheimer’s disease. We a...
Guardado en:
| Publicado en: | Sci Transl Med |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6762017/ https://ncbi.nlm.nih.gov/pubmed/30674654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aar4289 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|